Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ACM✓SelectedUSD · ACMGSK vs ACM performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs ACM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
ACM return
+2.4%
Excess return
+44.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioACMExcessAlpha
1D-0.1%+2.8%-2.9%-0.6%
7D-1.3%+3.3%-4.6%-1.9%
30D+2.7%+23.0%-20.3%-0.9%
3M+2.7%+15.5%-12.8%0.0%
6M+3.3%+2.7%+0.7%+2.5%
YTD+6.5%-22.7%+29.1%+10.3%
1Y+10.7%-44.8%+55.5%+22.5%
3Y+64.4%-13.7%+78.0%+62.5%
5Y+46.7%+4.3%+42.4%+34.0%
All+46.7%+2.4%+44.3%+34.0%

Cumulative growth

Daily Returns

Daily percentage return beside ACM.

Daily Out/Under-Performance

Portfolio return minus ACM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ACM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ACM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling